FBXO2 and Hepatic fibrosis: Conversely, overexpression of MCL1 in the liver protected against the pro-apoptotic effects of FBXO2+ SMEV treatment, further confirming the role of MCL1 in FBXO2+ SMEV-mediated hepatic fibrosis.